StockTipsArenaBeta

Piramal Pharma LimitedShare price targets & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹214.22-0.27 (-0.13%)
As of 4 Sept 2026
Analysts lean BUY·all 7 long-term calls are BUY·consensus 1Y target ₹234.29 (9.4% above CMP)
₹234.29
9.4% above CMP
₹220 – ₹245
7 active 1Y targets
12 open
12 BUY · 0 SELL (all horizons)
59%
20 of 34 closed calls hit
Watch PPLPHARMA for new buy/sell callsGet alertsSee 52 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (46) · loading…

BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI8+·3−+1.0% P&L+9.7% upside left
₹214.22
CMP
Entry*
₹212.19
Target
₹235
JIJefferies India· via Financial Express Market1w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI8+·3−+8.9% P&L+14.4% upside left
₹214.22
CMP
Entry*
₹196.72
Target
₹245
ISICICI Securities· via Institutional / Brokerage Research5w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI8+·3−+8.9% P&L+12.0% upside left
₹214.22
CMP
Entry*
₹196.72
Target
₹240
ISICICI Securities· via Institutional / Brokerage Research5w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI8+·3−+8.9% P&L+7.4% upside left
₹214.22
CMP
Entry*
₹196.72
Target
₹230
MOMotilal Oswal· via Institutional / Brokerage Research5w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI8+·3−+32.3% P&L+2.7% upside left
₹214.22
CMP
Entry*
₹161.87
Target
₹220
ISICICI Securities· via Institutional / Brokerage Research18w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI8+·3−+38.5% P&L+7.4% upside left
₹214.22
CMP
Entry*
₹154.68
Target
₹230
ISICICI Securities· via Institutional / Brokerage Research31w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)
AI8+·3−+7.5% P&L+12.0% upside left
₹214.22
CMP
Entry*
₹199.33
Target
₹240
MOMotilal Oswal· via Institutional / Brokerage Research43w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI8+·4−+4.30% realised0.0% upside left
Entry*
₹191.75
Target
₹200
hit 29 Jul 2026, 12:07 pm
JIJefferies India· via CNBC Awaaz.5w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+18.64% realised0.0% upside left
Entry*
₹160.15
Target
₹190
hit 7 May 2026, 12:05 pm
MOMotilal Oswal· via Institutional / Brokerage Research18w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
+23.63% realised0.0% upside left
Entry*
₹153.69
Target
₹190
hit 7 May 2026, 12:05 pm
MOMotilal Oswal· via Institutional / Brokerage Research31w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+23.72% realised0.0% upside left
Entry*
₹226.31
Target
₹280
hit 1 Nov 2024, 12:11 pm
ISICICI Securities· via Institutional / Brokerage Research101w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+14.89% realised0.0% upside left
Entry*
₹226.31
Target
₹260
hit 29 Oct 2024, 12:10 pm
MOMotilal Oswal· via Institutional / Brokerage Research101w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+23.76% realised0.0% upside left
Entry*
₹185.84
Target
₹230
hit 10 Sept 2024, 12:09 pm
ISICICI Securities· via Institutional / Brokerage Research107w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+20.11% realised0.0% upside left
Entry*
₹166.51
Target
₹200
hit 4 Sept 2024, 12:09 pm
ISICICI Securities· via Institutional / Brokerage Research110w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+38.69% realised0.0% upside left
Entry*
₹151.42
Target
₹210
hit 4 Sept 2024, 12:09 pm
ISICICI Securities· via Institutional / Brokerage Research110w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+71.27% realised0.0% upside left
Entry*
₹144.8
Target
₹248
hit 24 Oct 2024, 12:10 pm
VVentura· via Institutional / Brokerage Research117w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+17.73% realised0.0% upside left
Entry*
₹149.5
Target
₹176
hit 30 Jul 2024, 12:07 pm
HSHem Securities· via Institutional / Brokerage Research119w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+40.36% realised0.0% upside left
Entry*
₹148.9
Target
₹209
hit 4 Sept 2024, 12:09 pm
NWNuvama Wealth· via Institutional / Brokerage Research120w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+23.22% realised0.0% upside left
Entry*
₹154.2
Target
₹190
hit 8 Aug 2024, 12:08 pm
ISICICI Securities· via Institutional / Brokerage Research120w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+23.22% realised0.0% upside left
Entry*
₹154.2
Target
₹190
hit 8 Aug 2024, 12:08 pm
MOMotilal Oswal· via Institutional / Brokerage Research120w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Target hit
AI1+·0−+8.97% realised0.0% upside left
Entry*
₹137.65
Target
₹150
hit 3 May 2024, 12:05 pm
NWNuvama Wealth· via Institutional / Brokerage Research135w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI3+·4−-4.83% realisedNA upside left
₹195.68
At expiry
Entry*
₹205.61
Target
₹240
expired 29 Jul 2026, 3:30 pm
MOMotilal Oswal· via Institutional / Brokerage Research57w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI3+·4−-4.83% realisedNA upside left
₹195.68
At expiry
Entry*
₹205.61
Target
₹265
expired 29 Jul 2026, 3:30 pm
ISICICI Securities· via Institutional / Brokerage Research57w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
-16.17% realisedNA upside left
₹174.87
At expiry
Entry*
₹208.61
Target
₹250
expired 15 May 2026, 3:30 pm
MOMotilal Oswal· via Institutional / Brokerage Research68w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
-33.11% realisedNA upside left
₹154.68
At expiry
Entry*
₹231.25
Target
₹283
expired 30 Jan 2026, 3:30 pm
NWNuvama Wealth· via Institutional / Brokerage Research83w ago
BUYPPLPHARMAPiramal Pharma1 Year* (horizon not stated by the source; assumed from the target's distance)Expired
AI1+·0−-20.90% realisedNA upside left
₹202.37
At expiry
Entry*
₹255.84
Target
₹310
expired 24 Oct 2025, 3:30 pm
MOMotilal Oswal· via Institutional / Brokerage Research97w ago
BUYPPLPHARMAPiramal Pharma1–3 Months
AI8+·3−+0.9% P&L+25.1% upside left
₹214.22
CMP
Entry*
₹212.3
Target
₹268
RKRachit Khandelwal· via Business Today1w ago
BUYPPLPHARMAPiramal Pharma1–3 Months* (horizon not stated by the source; assumed from the target's distance)
AI8+·3−+2.5% P&L+9.7% upside left
₹214.22
CMP
Entry*
₹208.93
Target
₹235
RDRupak De, LKP Securities· via Business Today4w ago
BUYPPLPHARMAPiramal Pharma1–3 Months* (horizon not stated by the source; assumed from the target's distance)
AI8+·3−+6.2% P&L+2.7% upside left
₹214.22
CMP
Entry*
₹201.75
Target
₹220
OKOsho Krishan, Angel One· via Business Today4w ago
BUYPPLPHARMAPiramal Pharma1–3 Months* (horizon not stated by the source; assumed from the target's distance)Target hit
AI14+·3−+7.74% realised0.0% upside left
Entry*
₹202.34
Target
₹218
hit 10 Aug 2026, 12:08 pm
OKOsho Krishan, Angel One· via Business Today4w ago
BUYPPLPHARMAPiramal Pharma1–3 Months* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-4.76% realisedNA upside left
SL
₹168.2
Entry
₹176.6
Target
₹196
hit 3 Jul 2026, 2:14 pm
ICIDBI Capital· via IDBI Capital Research Calls Telegram9w ago
BUYPPLPHARMAPiramal Pharma1–3 MonthsExpired
AI16+·3−+20.25% realisedNA upside left
₹211.29
At expiry
Entry*
₹175.71
Target
₹240
expired 27 Aug 2026, 3:30 pm
AJAnshul Jain, Lakshmishree Investment and Securities· via Business Today14w ago
BUYPPLPHARMAPiramal Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)
AI7+·3−-0.3% P&L+7.4% upside left
₹214.22
CMP
SL
₹208
Entry
₹214.95
Target
₹230
DMDeven Mehata, IDBI Capital Markets and Securities· via NDTV Profit (Live)1w ago
BUYPPLPHARMAPiramal Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)
AI6+·3−-0.4% P&L+7.4% upside left
₹214.22
CMP
SL
₹208
Entry
₹215
Target
₹230
ICIDBI Capital· via IDBI Capital Research Calls Telegram1w ago
BUYPPLPHARMAPiramal Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI12+·4−+8.84% realised0.0% upside left
SL
₹193
Entry*
₹199.37
Target
₹217
hit 10 Aug 2026, 10:25 am
MBMadhu Bansal· via CNBC Awaaz.5w ago
BUYPPLPHARMAPiramal Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI9+·4−+7.70% realised0.0% upside left
SL
₹189
Entry*
₹194.99
Target
₹210
hit 6 Aug 2026, 9:25 am
RPRajesh Palviya, Axis Securities· via Business Today5w ago
BUYPPLPHARMAPiramal Pharma1–2 WeeksTarget hit
AI9+·4−+5.27% realised0.0% upside left
SL
₹192
Entry*
₹195.68
Target
₹206
hit 5 Aug 2026, 10:05 am
RBRakesh Bansal· via Zee Business (Live)5w ago
BUYPPLPHARMAPiramal Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI9+·4−+8.59% realised0.0% upside left
SL
₹188
Entry*
₹193.38
Target
₹210
hit 6 Aug 2026, 9:25 am
NCNeerav Chheda, Nirmal Bang Securities· via CNBC Awaaz.5w ago
BUYPPLPHARMAPiramal Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Target hit
AI3+·3−+6.83% realised0.0% upside left
SL
₹170.5
Entry
₹176.45
Target
₹188.5
hit 27 Jul 2026, 10:00 am
ICIDBI Capital· via IDBI Capital Research Calls Telegram7w ago
BUYPPLPHARMAPiramal Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI4+·2−-2.35% realisedNA upside left
SL
₹208
Entry
₹213
Target
₹223
hit 25 Aug 2026, 9:35 am
ICIDBI Capital· via IDBI Capital Research Calls Telegram2w ago
BUYPPLPHARMAPiramal Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI3+·3−-2.73% realisedNA upside left
SL
₹178
Entry
₹183
Target
₹193
hit 22 Jul 2026, 9:50 am
ICIDBI Capital· via IDBI Capital Research Calls Telegram6w ago
BUYPPLPHARMAPiramal Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-4.87% realisedNA upside left
SL
₹168
Entry*
₹176.6
Target
₹195
hit 8 Jul 2026, 2:55 pm
SMSomil Mehta, Sharekhan· via CNBC Awaaz.9w ago
BUYPPLPHARMAPiramal Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
AI2+·0−-4.15% realisedNA upside left
SL
₹171
Entry*
₹178.4
Target
₹195
hit 8 Jul 2026, 2:05 pm
RDRupak De, LKP Securities· via Zee Business (Live)9w ago
BUYPPLPHARMAPiramal Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Stop-loss hit
-2.98% realisedNA upside left
SL
₹179
Entry
₹184.5
Target
₹195
hit 12 May 2026, 10:55 am
RDRupak De, LKP Securities· via CNBC Awaaz.16w ago
BUYPPLPHARMAPiramal Pharma1–2 Weeks* (horizon not stated by the source; assumed from the target's distance)Expired
AI9+·4−+9.38% realisedNA upside left
₹202.14
At expiry
SL
₹173
Entry*
₹184.81
Target
₹220
expired 4 Aug 2026, 3:30 pm
VKVishnu Kant Upadhyay, Master Capital Services· via Business Today6w ago
BUYPPLPHARMAPiramal PharmaIntraday* (horizon not stated by the source; assumed from the target's distance)Expired
AI2+·0−-1.51% realisedNA upside left
₹213.98
At expiry
SL
₹212
Entry*
₹217.25
Target
₹222
expired 2 Sept 2026, 3:20 pm
KHKunal Hasmukhlal Shah· via Zee Business (Live)4d ago
StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.